You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0347 Subcutaneuos (sc) methotrexate (mtx) in patients with rheumatoid arthritis (ra) as a part of “treat to target” (t2t) strategy in real practice: preliminary results of remarca study

Article metrics

Article menu
Download PDFPDF
Abstracts accepted for publication
Rheumatoid arthritis - non biologic treatment
AB0347 Subcutaneuos (sc) methotrexate (mtx) in patients with rheumatoid arthritis (ra) as a part of “treat to target” (t2t) strategy in real practice: preliminary results of remarca study

 

Online download statistics by month:

Online download statistics by month: February 2014 to February 2024

AbstractFullPdf
Feb 20141402
Mar 20141001
Apr 20141200
May 20141100
Jun 2014100
Jul 2014200
Aug 2014601
Sep 2014300
Oct 2014502
Nov 20141001
Dec 20141001
Jan 2015200
Feb 2015200
Mar 20151001
Apr 2015400
May 2015600
Jun 2015300
Jul 2015300
Aug 2015700
Sep 2015600
Oct 2015800
Nov 2015500
Dec 2015301
Jan 2016201
Feb 2016200
Mar 2016300
Apr 2016100
May 2016500
Jun 2016701
Jul 2016500
Aug 2016300
Sep 2016400
Oct 2016300
Nov 2016600
Dec 2016400
Jan 2017501
Feb 2017100
Mar 2017700
Apr 2017600
May 20171100
Jun 2017600
Jul 20171000
Aug 2017800
Sep 2017600
Oct 2017400
Nov 2017600
Dec 2017600
Jan 2018600
Feb 2018800
Mar 20181200
Apr 20181200
May 20186001
Jun 20181000
Jul 20181001
Aug 20181600
Sep 2018800
Nov 2018400
Dec 2018200
Feb 2019200
Mar 2019600
Apr 2019600
May 2019400
Jun 2019200
Oct 2019200
Jul 2020200
Sep 2020600
Oct 2020200
Nov 2020300
Dec 2020500
Jan 2021400
Mar 2021700
Apr 2021200
Aug 2021103
Oct 2021402
Nov 2021200
Dec 2021800
Jan 2022600
Feb 2022400
Mar 2022200
Apr 2022400
May 2022800
Jun 2022200
Jul 20221200
Aug 2022400
Sep 2022400
Oct 2022200
Nov 2022400
Dec 2022400
Jan 2023400
Feb 2023400
Apr 2023200
May 2023800
Jul 2023200
Aug 2023200
Sep 2023800
Oct 2023200
Dec 2023600
Jan 2024400
Feb 2024200
Total580020